vs
Cytek Biosciences, Inc.（CTKB）与合众银行（FSBC）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是合众银行的1.4倍（$62.1M vs $45.1M），合众银行净利率更高（41.3% vs -70.9%，领先112.2%），过去两年合众银行的营收复合增速更高（21.3% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
合众银行是总部设在美国明尼阿波利斯、在特拉华州注册的美国跨国银行机构，截至2025年为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的银行。它旗下核心运营实体为美国银行全国协会，以US Bank品牌开展业务，提供银行、投资、抵押等金融服务。
CTKB vs FSBC — 直观对比
营收规模更大
CTKB
是对方的1.4倍
$45.1M
净利率更高
FSBC
高出112.2%
-70.9%
两年增速更快
FSBC
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $45.1M |
| 净利润 | $-44.1M | $18.6M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | — |
| 净利率 | -70.9% | 41.3% |
| 营收同比 | 8.1% | — |
| 净利润同比 | -557.1% | 42.0% |
| 每股收益（稀释后） | — | $0.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBFSBC
| Q1 26 | — | $45.1M | ||
| Q4 25 | $62.1M | $43.5M | ||
| Q3 25 | $52.3M | $41.3M | ||
| Q2 25 | $45.6M | $38.3M | ||
| Q1 25 | $41.5M | $35.3M | ||
| Q4 24 | $57.5M | $35.2M | ||
| Q3 24 | $51.5M | $31.8M | ||
| Q2 24 | $46.6M | $30.7M |
净利润CTKBFSBC
| Q1 26 | — | $18.6M | ||
| Q4 25 | $-44.1M | $17.6M | ||
| Q3 25 | $-5.5M | $16.3M | ||
| Q2 25 | $-5.6M | $14.5M | ||
| Q1 25 | $-11.4M | $13.1M | ||
| Q4 24 | $9.6M | $13.3M | ||
| Q3 24 | $941.0K | $10.9M | ||
| Q2 24 | $-10.4M | $10.8M |
毛利率CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
营业利润率CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 52.9% | ||
| Q3 25 | -17.6% | 53.8% | ||
| Q2 25 | -23.3% | 52.4% | ||
| Q1 25 | -36.1% | 52.0% | ||
| Q4 24 | 5.2% | 55.1% | ||
| Q3 24 | -8.2% | 48.0% | ||
| Q2 24 | -18.3% | 49.4% |
净利率CTKBFSBC
| Q1 26 | — | 41.3% | ||
| Q4 25 | -70.9% | 40.6% | ||
| Q3 25 | -10.5% | 39.6% | ||
| Q2 25 | -12.2% | 37.9% | ||
| Q1 25 | -27.5% | 37.1% | ||
| Q4 24 | 16.8% | 37.9% | ||
| Q3 24 | 1.8% | 34.4% | ||
| Q2 24 | -22.4% | 35.2% |
每股收益（稀释后）CTKBFSBC
| Q1 26 | — | $0.87 | ||
| Q4 25 | — | $0.83 | ||
| Q3 25 | — | $0.77 | ||
| Q2 25 | — | $0.68 | ||
| Q1 25 | — | $0.62 | ||
| Q4 24 | — | $0.61 | ||
| Q3 24 | — | $0.52 | ||
| Q2 24 | — | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $644.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $458.5M |
| 总资产 | $461.5M | $5.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBFSBC
| Q1 26 | — | $644.4M | ||
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — |
股东权益CTKBFSBC
| Q1 26 | — | $458.5M | ||
| Q4 25 | $341.7M | $445.8M | ||
| Q3 25 | $378.6M | $431.3M | ||
| Q2 25 | $377.6M | $416.7M | ||
| Q1 25 | $379.6M | $406.5M | ||
| Q4 24 | $395.7M | $396.6M | ||
| Q3 24 | $385.5M | $389.9M | ||
| Q2 24 | $389.1M | $380.5M |
总资产CTKBFSBC
| Q1 26 | — | $5.0B | ||
| Q4 25 | $461.5M | $4.8B | ||
| Q3 25 | $494.9M | $4.6B | ||
| Q2 25 | $493.3M | $4.4B | ||
| Q1 25 | $482.6M | $4.2B | ||
| Q4 24 | $499.5M | $4.1B | ||
| Q3 24 | $491.2M | $3.9B | ||
| Q2 24 | $483.7M | $3.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | — |
| 自由现金流率自由现金流/营收 | -2.9% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.8M | — |
8季度趋势，按日历期对齐
经营现金流CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $72.6M | ||
| Q3 25 | $-3.9M | $18.8M | ||
| Q2 25 | $108.0K | $17.8M | ||
| Q1 25 | $-125.0K | $15.5M | ||
| Q4 24 | $2.0M | $51.8M | ||
| Q3 24 | $13.2M | $17.5M | ||
| Q2 24 | $6.2M | $16.0M |
自由现金流CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $71.4M | ||
| Q3 25 | $-4.6M | $18.6M | ||
| Q2 25 | $-1.5M | $17.5M | ||
| Q1 25 | $-974.0K | $15.4M | ||
| Q4 24 | $1.1M | $51.2M | ||
| Q3 24 | $12.2M | $17.3M | ||
| Q2 24 | $5.2M | $15.8M |
自由现金流率CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 164.3% | ||
| Q3 25 | -8.7% | 45.0% | ||
| Q2 25 | -3.2% | 45.8% | ||
| Q1 25 | -2.3% | 43.5% | ||
| Q4 24 | 1.9% | 145.5% | ||
| Q3 24 | 23.7% | 54.5% | ||
| Q2 24 | 11.0% | 51.6% |
资本支出强度CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 2.8% | ||
| Q3 25 | 1.3% | 0.5% | ||
| Q2 25 | 3.5% | 0.6% | ||
| Q1 25 | 2.0% | 0.3% | ||
| Q4 24 | 1.6% | 1.8% | ||
| Q3 24 | 2.0% | 0.7% | ||
| Q2 24 | 2.3% | 0.7% |
现金转化率CTKBFSBC
| Q1 26 | — | — | ||
| Q4 25 | — | 4.12× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.23× | ||
| Q1 25 | — | 1.18× | ||
| Q4 24 | 0.21× | 3.89× | ||
| Q3 24 | 14.05× | 1.60× | ||
| Q2 24 | — | 1.49× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FSBC
| Net Interest Income | $43.5M | 96% |
| Noninterest Income | $1.6M | 4% |
